Section 661.10  Responsibility

a)         The physician in attendance at or immediately after the birth of the newborn infant shall have primary responsibility for seeing that a specimen of the infant's blood is screened in accordance with this Part.  Newborn screening includes tests for the following disorders: classical phenylketonuria (PKU) and certain other amino acid, organic acid, and fatty acid oxidation disorders; primary hypothyroidism; classical galactosemia; congenital adrenal hyperplasia due to 21-hydroxylase deficiency; biotinidase deficiency; sickle cell disease/trait; and cystic fibrosis.  Specific diseases in the categories of amino acid, organic acid, and fatty acid oxidation will be determined by the Director.  For a current list of disorders refer to the Illinois Department of Public Health Newborn Screening Practitioner's Manual.  A blood specimen meeting the requirements for testing shall suffice for all tests (see Section 661.20).  The physician may delegate this responsibility to the hospital administrator or to the administrator's designated representative, such as a member of the pediatrics staff, the laboratory director, the obstetrical supervisor, or other hospital official.

b)         If the infant is not born in or admitted to a hospital or when there is no physician in attendance at or immediately after the birth, the physician caring for the infant during the first month of life shall be the individual responsible for seeing that a blood specimen for newborn screening is submitted.  When there is no physician caring for such an infant during this period, the parents or guardian is responsible.  Local health authorities or the Department shall assist the parents or guardian in having a blood specimen submitted for testing.

c)         All specimens collected pursuant to this Part shall be submitted for testing to the Newborn Screening Section, Division of Laboratories, Illinois Department of Public Health, 2121 West Taylor Street, Chicago, Illinois 60612 (see Section 661.20).

d)         When a retest is determined to be necessary pursuant to Section 661.30 of this Part, the Illinois Department of Public Health shall notify the physician or his or her designee who is responsible for obtaining another specimen and having the specimen tested.

(Source:  Amended at 31 Ill. Reg. 13203, effective August 28, 2007)